Dandrit ‘s technique is based on Dendritic Cells,  garland science made this easy-to-understand youtube video on the development of Dendritic Cells


this stops at where the T-cells enters :)…

but don’t despair I’ve found another from KhanAcademy.org on the  cytotoxic T-cells http://www.youtube.com/watch?v=xaz5ftvZCyI&feature=related  (these are the cells that attack cancer-cells)

So far the only FDA approved vaccine is Provenge by Dendreon


So far no video has been made on Dandrit’s MelCancerVac – lets hope a cash-infusion will change that – untill tehn we will have to make do with this written explanation of the process http://dandrit.dk/technology/vaccine-platform


About Stengaard

BioPorto investor from way back when... I've invested in BioPorto ever since they made their debut on the danish stock exchange, it been a looooong journey with many obstacles. But well worth it all if Bioporto maintains their patent after the proceedings in 2014, and enters into agreements with Global Distributors in 2012 and 2013 If not, then it'll take another xx.years 🙂

Tagged with:

One Response to Dendritic Cells explained, Provenge, Dandrit

  1. Steinhof-I-pressume says:

    Dendreon (DNDN) faces competition from other large companies such as Johnson/Johnson – here is an interesting contrarian article about the progress of J&J's Zytiga …. http://seekingalpha.com/article/642161-asco-data-

    The overall conclusion from this catfight is that cancer vaccine will be a focus area. I've no doubt that this will eventually mean that Dandrit will be swallowed by one of the major players.

    Based on the fact that Dendreon seems to have most to gain by keeping cometitors out of the market taht they see as theirs (being first movers) I see clear advantages for Dendreon by aquiring Dandrit

Leave a Reply

Your email address will not be published. Required fields are marked *

Set your Twitter account name in your settings to use the TwitterBar Section.